A detailed history of Buckingham Strategic Wealth, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 2,894 shares of MRNA stock, worth $116,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,894
Previous 2,907 0.45%
Holding current value
$116,541
Previous $309,000 11.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $1,315 - $2,165
-13 Reduced 0.45%
2,894 $343,000
Q1 2024

May 09, 2024

BUY
$85.37 - $115.44 $43,624 - $58,989
511 Added 21.33%
2,907 $309,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $5,699 - $8,563
82 Added 3.54%
2,396 $238,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $10,219 - $13,420
-106 Reduced 4.38%
2,314 $239,000
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $5,806 - $7,865
-49 Reduced 1.98%
2,420 $294,000
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $17,046 - $30,245
144 Added 6.19%
2,469 $443,000
Q3 2022

Nov 07, 2022

SELL
$118.07 - $194.18 $2,597 - $4,271
-22 Reduced 0.94%
2,325 $275,000
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $22,371 - $33,728
-191 Reduced 7.53%
2,347 $335,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $24,533 - $45,599
194 Added 8.28%
2,538 $437,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $143,847 - $234,740
637 Added 37.32%
2,344 $595,000
Q3 2021

Nov 10, 2021

SELL
$221.9 - $484.47 $77,443 - $169,080
-349 Reduced 16.97%
1,707 $657,000
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $16,368 - $29,607
126 Added 6.53%
2,056 $483,000
Q1 2021

Apr 30, 2021

BUY
$109.18 - $185.98 $210,717 - $358,941
1,930 New
1,930 $253,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Buckingham Strategic Wealth, LLC Portfolio

Follow Buckingham Strategic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.